B Cell Depletion and <scp>SARS‐CoV</scp>‐2 Vaccine Responses in Neuroimmunologic Patients

Abstract

Antibody responses to SARS-CoV-2 mRNA vaccinnation can be attained in patients on anti-CD20 therapy by the onset of B cell repopulation. In the absence of B cells, a strong T cell response is generated which may help to protect against severe coronavirus disease 2019 (COVID-19) in this high-risk population. ANN NEUROL 2022;91:342-352.